Crednology Holding Corp. CEO Issues Letter to Shareholders
May 01, 2018 10:35 am UTC| Business
Northridge, CA, May 01, 2018 -- Crednology Holding Corp. (OTC Pink: COHO; "Crednology"). Letter to our Shareholders This goal of this letter is to provide clarity and additional information on previous...
$27.2 Billion Artificial Intelligence in Retail Market - Global Analysis and Forecasts to 2025
May 01, 2018 10:30 am UTC| Business
Dublin, May 01, 2018 -- The "Artificial Intelligence in Retail Market 2025 - Global Analysis and Forecasts by Deployment Type, Retail Type, Technology and Application" report has been added to ...
The Carlyle Group Announces First Quarter 2018 Financial Results
May 01, 2018 10:30 am UTC| Business
WASHINGTON, May 01, 2018 -- Global alternative asset manager The Carlyle Group L.P. (NASDAQ:CG) today reported its unaudited results for the first quarter ended March 31, 2018. Carlyle Co-CEOs Kewsong Lee and Glenn...
ChromaDex Remains Confident Amidst Inter Partes Review (IPR) Procedural Changes
May 01, 2018 10:30 am UTC| Business
IRVINE, Calif., May 01, 2018 -- ChromaDex Corp. (NASDAQ:CDXC), an integrated, science-based, nutraceutical company devoted to improving the way people age, announced today that the Patent Trial and Appeal Board (PTAB)...
Southside Bancshares, Inc. Announces Financial Results for the Three Months Ended March 31, 2018
May 01, 2018 10:30 am UTC| Business
TYLER, Texas, May 01, 2018 -- Southside Bancshares, Inc. (“Southside” or the “Company”) (NASDAQ:SBSI) today reported its financial results for the three months ended March 31, 2018. Southside reported net income of...
Edge Therapeutics Reports First Quarter 2018 Financial Results
May 01, 2018 10:30 am UTC| Business
BERKELEY HEIGHTS, N.J., May 01, 2018 -- Edge Therapeutics, Inc. (Nasdaq:EDGE) today announced financial results for the quarter ended March 31, 2018. First Quarter Financial Results Cash Position: Cash, cash...
AnaptysBio Announces ANB020 and ANB019 Clinical Data Presentations at the 2018 EAACI Congress
May 01, 2018 10:30 am UTC| Business
SAN DIEGO, May 01, 2018 -- AnaptysBio, Inc. (Nasdaq:ANAB), a clinical-stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation, today announced...